Clearmind Medicine Inc. Quarterly Research And Development Expense in USD from Q1 2022 to Q3 2024

Taxonomy & unit
ifrs-full: CAD and USD
Summary
Clearmind Medicine Inc. quarterly/annual Research And Development Expense history and growth rate from Q1 2022 to Q3 2024.
  • Clearmind Medicine Inc. Research And Development Expense for the quarter ending October 31, 2024 was $486K, a 29.7% increase year-over-year.
  • Clearmind Medicine Inc. Research And Development Expense for the twelve months ending October 31, 2024 was $1.38M, a 10.5% decline year-over-year.
  • Clearmind Medicine Inc. annual Research And Development Expense for 2024 was $1.38M, a 10.5% decline from 2023.
  • Clearmind Medicine Inc. annual Research And Development Expense for 2023 was $1.54M, a 49.9% decline from 2022.
  • Clearmind Medicine Inc. annual Research And Development Expense for 2022 was $3.08M, a 550% increase from 2021.
Research And Development Expense, Trailing 12 Months (USD)
Research And Development Expense, Quarterly (USD)
Research And Development Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.38M $486K +$111K +29.7% Aug 1, 2024 Oct 31, 2024 20-F 2025-01-22
Q2 2024 $1.27M $346K +$81.9K +31% May 1, 2024 Jul 31, 2024 6-K 2024-09-16
Q1 2024 $1.19M $323K +$5.38K +1.7% Feb 1, 2024 Apr 30, 2024 6-K 2024-06-13
Q4 2023 $1.18M $227K -$360K -61.3% Nov 1, 2023 Jan 31, 2024 6-K 2024-03-19
Q3 2023 $1.54M $375K Aug 1, 2023 Oct 31, 2023 20-F 2025-01-22
Q2 2023 $264K May 1, 2023 Jul 31, 2023 6-K 2024-09-16
Q1 2023 $318K -$843K -72.6% Feb 1, 2023 Apr 30, 2023 6-K 2024-06-13
Q4 2022 $588K Nov 1, 2022 Jan 31, 2023 6-K 2024-03-19
Q1 2022 $1.16M Feb 1, 2022 Apr 30, 2022 6-K 2023-06-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.